Non steroidal anti-inflammatory drugs (NSAID's) are first line therapeutic agents for the treatment of arthritis. NSAID's reduce the pain and swelling associated with arthritis by blocking the metabolism of arachidonic acid (AA) through the enzyme cyclooxygenase (COX) and thereby the production of prostaglandins, e.g. PGE 2 , which sensitizes nociceptors at nerve fiber terminals. 1, 2) Additionally, the 5-lipoxygenase (5-LO) products such as leukotriene B 4 (LTB 4 ) also contributes to the hyperalgesia seen during inflammation by decreasing the mechanical and thermal thresholds of C fiberes.
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3) Leukotrienes, especially LTB 4 together with prostaglandins are implicated in the acute ulceration induced by NSAID's. 4) For these reasons, compounds that achieve dual inhibition of enzymes COX and 5-LO reduce side effects and improved efficacy in the combat of pain in inflammatory diseases. 5) Some evidences suggest that the hydrazone moiety present in phenylhydrazone derivative 1 (Fig. 1) , possesses a pharmacophoric character for the inhibition of COX and hydrazone type containing compounds such as compound 2 ( Fig. 1) were described as dual COX/5-LO inhibitors. 6, 7) According to these evidences, there are some reports about synthesis and pharmacological evaluation of new bioactive compounds with N-aroylarylhydrazone structure acting at the AA cascade enzyme level (Fig. 2, compounds 3-5). [8] [9] [10] On the basis of these reports, we described previously the synthesis and analgesic profile of Narylhydrazone derivatives of mefenamic acid 6 (Fig. 3) , a known NSAID drug with fenamate structure. 11) Most of these synthesized compounds were effective as analgesic agents in comparison to control and showed more analgesic activity in comparison to mefenamic acid. In fact, compound 7 ( Fig. 3 ) displayed 3.6-fold greater potency than mefenamic acid as an analgesic agent, in a model of abdominal constrictions induced by acetic acid. These results led us to design new structurally related derivatives 10, 11. Target compounds 10, 11 were obtained according to Chart 1. The starting hydrazides 8 (XϭO, RϭH and XϭNH, RϭH) were prepared by the known procedures and hydrazide 8 (XϭO, RϭCl) was synthesized as described previously. [12] [13] [14] [15] [16] [17] Compounds 10, 11 were synthesized by acid-catalyzed condensation of hydrazides 8 with corresponding substituted benzaldehydes or acetophenones. 10, 11) The synthesis and antimicrobial activity ethanol (20 ml) was stirred at room temperature for 0.5 to 1 h, in the presence of hydrochloric acid (2 drops) as a catalyst. The end of the reaction was observed by TLC, and the hydrazones 10a-11j were isolated by concentration of the reaction mixture uner reduced pressure, followed by neutralization with a 10% aqueous solution of sodium bicarbonate. The resulting precipitate was filtered, washed with water (10 ml) and crystallized from a suitable solvent. Melting points, crystallization solvents and yields are reported in Table 1 . The spectral data of the synthesized compounds are as follows:
2-Phenoxybezoic Acid (Benzylidene)hydrazide 10a: 
PHARMACOLOGY
Male NMRI weighing 20-25 g (Razi Institute of Iran) were used for the abdominal constriction test (writhing test). The animals were housed in colony cages and conditions of constant temperature (22Ϯ2°C) and a 12 h light/dark schedule and allowed free access to standard diet and tap water except during the experiment. The animals were allowed to habituate to the laboratory environment for 2 h before the experiments were initiated. All ethical manners for use of laboratory animals were considered carefully and the protocol of study was approved by TUMS ethical committee. The compounds were administered intraperitoneally (IP) (0.2 ml/20 g) as suspension in saline and tween 80 (2% w/v). Indomethacin, 20) diclofenac sodium, 21) mefenamic acid 22) (Hakim Pharmaceutical Co.) were used as standard drugs under the same conditions. The control group received vehicle (0.2 ml/20 g, IP) alone.
Abdominal Constrication Test The Analgesic activity was determined in vivo by the abdominal constriction test induced by acetic acid (0.6%; 0.1 ml/10 g) in mice. 23) An acetic acid solution was administered IP 30 min after administration of the compounds. Antinociception was recorded by counting the number of writhings immediately after injection of acetic acid during 30 min. The analgesic activity was expressed as the percentage of inhibition of constrictions when compared with the vehicle control group. The data were statistically analyzed by one way analysis of Variance (ANOVA) followed by Newman-Keuls multi comparison test, differences with pϽ0.05 between experimental groups were considered statistically significant. The ED 50 values (the dose of compound that reduced responses by 50% in relation to control values) were estimated by graphical interpolation from individual experiments. ED 50 's are presented as mean values and 95% confidence interval.
Formalin-Induced Test The most active compounds were also analysed in the formalin-induced pain test. 24) Twenty microliters of 5% (0.92% formaldehyde) made up PBS (phosphate buffered solution, containing: NaCl 137 mM; KCl 2.7 mM and phosphate buffer 10 mM) was injected s.c. under the plantar surface of the left hindpaw with a Hamilton syringe. Animnals were acclimatized to the laboratory for at least 24 h before the experiments. Two mice (control and treated) were simultaneously observed from 0 up to 30 min following formalin injection. The initial nociceptive scores normally peaked after 5 min (first phase, representing the neurogenic pain), and 15-30 min after formalin injection (second phase, representing the inflammatory pain). The animals were treated with saline 0.9% (10 ml/kg, i.p.) or with test compounds 30 min before formalin injection. After intraplantar irritant application, the animals were immediately placed into a glass cylinder (20 cm diameter). The time spent by animals licking or biting the injected paw was measured with a chronometer and was considered indicative of pain.
RESULT AND DISCUSSION
As shown in Table 2 , several synthesized derivatives exhibited potent antinociceptive effect when assessed by the writhing test in mice. In the first series of derivatives (10a-l), compounds 10b, 10d and 10g were the most potent compounds and their activity were comparable to indomethacin, diclofenac sodium and mefenamic acid. In fact they are 2.1, 2.3 and 1.5 fold more potent than mefenamic acid respectively.
Comparison of compounds 10b and 10d with 10c and 10e, respectively, proves that the introduction of a methyl group in the NϭC double bond of the hydrazone moiety reduces the analgesic activity. These results may indicate that the methyl group in 10c and 10e blocks the imine framework of the aroyl arylhydrazone moiety in the bioreceptor recognition, contributing to reduction of the analgesic activity. 9) In NSAID's with fenamate structure, substituents on N-aryl ring which force this ring to be non-coplanar with the anthranilic acid ring can enhance binding to the receptor. 25) Because of this fact we synthesized the second series of derivatives (10m-v) which possess ortho-chlorine on 2-phenoxy moiety in order to have more potent compounds. However, this strategy not only didn't increase their analgesic effect but 1184 Vol. 29, No. 6 10b, 10d, 10f-g and 11c-j) 
